Abstract

Rehydrated, lyophilized platelets for hemostatic therapy are incorporated with commercial MRI iron oxide contrast agents. We demonstrate that magnetomotive OCT contrasts the platelets and propose this system for monitoring hemopathic sites targeted by platelets.

© 2010 OSA

PDF Article